Liv Sagatun
Trondheim, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The Use of Proton Pump Inhibitors Among Adults in Norway-A Nationwide Drug Utilization Study.
Journal: Pharmacology research & perspectives
Published: June 26, 2025
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: September 23, 2020
Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation.
Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
Published: October 04, 2017
Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.
Journal: Hormones & cancer
Published: July 20, 2017
The gastrin receptor antagonist netazepide (YF476) in patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours: review of long-term treatment.
Journal: European journal of gastroenterology & hepatology
Published: September 30, 2016
Follow-up of patients with ECL cell-derived tumours.
Journal: Scandinavian journal of gastroenterology
Published: June 17, 2016
Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
Journal: British journal of clinical pharmacology
Published: May 09, 2016
Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: September 22, 2014
The gastric mucosa 25 years after proximal gastric vagotomy.
Journal: Scandinavian journal of gastroenterology
Published: August 27, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026